Moreover, a negative correlation was found between plasma resistin levels and HDL-C cholesterol in CRC patients, suggesting that HDL-C cholesterol may be involved in the modifications of the secretion process of resistin in CRC [83]. The gene discussed is RETN; the disease is colorectal carcinoma.